HPLC · CoA
Ipamorelin vs MK-677: What Is the Difference?
Comparison · 6 min read · Updated 30 September 2026
The difference between Ipamorelin vs MK-677 is chemical class: both activate the ghrelin receptor GHS-R1a, but Ipamorelin is a synthetic pentapeptide of about 712 daltons with a short, pulse-like action, while MK-677, also called ibutamoren, is an orally active non-peptide small molecule with a sustained action. Ipamorelin is also noted for selectivity, releasing growth hormone with little change in ACTH or cortisol in animal work. We supply Ipamorelin as a lyophilised research peptide and do not sell MK-677.
How Do Ipamorelin and MK-677 Reach the Same Receptor?
Ipamorelin and MK-677 reach the same receptor because both came from programmes targeting the pituitary growth hormone secretagogue receptor, one by peptide design and one by small molecule screening. The receptor was defined pharmacologically before its natural ligand was known: growth hormone releasing peptides from the 1980s, such as GHRP-6 and GHRP-2, revealed a pituitary receptor distinct from the GHRH receptor.
The peptide programme produced Ipamorelin, which the European Journal of Endocrinology (1998) introduced as the first selective member of its class. The small molecule programme screened for compounds that could reach the same receptor and survive the gut, leading to the spiropiperidine series and MK-677 in the mid 1990s. Ghrelin itself was reported in Nature in 1999.
Ipamorelin vs MK-677 at a Glance
| Feature | Ipamorelin | MK-677 (ibutamoren) |
|---|---|---|
| Chemical class | synthetic pentapeptide | non-peptide spiropiperidine small molecule |
| Structure | Aib, His, D-2-Nal, D-Phe, Lys, amidated | spiro-indoline piperidine core with a sulfonyl group |
| Molecular weight | about 712 Da | about 529 Da as free base, about 625 Da as mesylate salt |
| Receptor | GHS-R1a agonist | GHS-R1a agonist |
| Oral activity | no, degraded like other peptides | yes, orally active in animal models |
| Duration of action | short, pulse-like | long, sustained |
| Selectivity in early work | little effect on ACTH, cortisol or prolactin in animal studies | broader endocrine profile reported |
| Supplied by Macropus Peptides | yes, 10mg vials | no |
Why Does the Chemistry Matter for Study Design?
The chemistry matters because a short-acting peptide and a long-acting small molecule produce different patterns of receptor activation over time. A peptide gives a discrete pulse that fades quickly, which suits studies of pulsatile release, short-window receptor desensitisation and acute pituitary responses. A small molecule keeps the receptor engaged continuously, which suits questions about sustained stimulation, tolerance and feeding behaviour in animal models. Neither is superior in general; they address different questions about the same receptor.
Which Is More Selective, Ipamorelin or MK-677?
Ipamorelin is the more selective of the two in the published animal work, releasing growth hormone with little change in ACTH, cortisol or prolactin even at high levels. Older secretagogues such as GHRP-2 research peptide raised those hormones as well, and MK-677 has a broader reported endocrine profile. That clean profile makes Ipamorelin the standard choice for experiments requiring ghrelin receptor input with minimal hormonal interference.
Is CJC-1295 + Ipamorelin Different From MK-677?
CJC-1295 + Ipamorelin is different from MK-677 because the pair activates two pituitary receptors, while MK-677 activates only the ghrelin receptor. Both of those receptor inputs converge on the same somatotroph cells and produce a larger response in models than either input alone, with somatostatin tone shaping both.
Our CJC-1295 and Ipamorelin 10mg blend holds the two peptides as one lyophilised cake. A study asking whether dual receptor input differs from single receptor input would compare the blend, Ipamorelin alone and a GHRH analogue alone. That is a cleaner design than comparing a peptide blend with a small molecule of different duration and chemistry.
What Is the Difference Between MK-677 and Tesamorelin?
MK-677 and tesamorelin differ in receptor: MK-677 acts on the ghrelin receptor and raises calcium, while tesamorelin signals through GHRH receptors, increasing cyclic AMP. Tesamorelin is a 44 residue analogue of full-length GHRH with a trans-3-hexenoyl group on the N-terminal tyrosine, weighing about 5,136 daltons. That acyl group shields the molecule from DPP-4 cleavage, which inactivates native GHRH within minutes.
| Feature | Tesamorelin | MK-677 |
|---|---|---|
| Receptor | GHRH receptor | GHS-R1a |
| Second messenger | cyclic AMP | calcium, via Gq |
| Class | 44 residue modified peptide | small molecule |
| Mimics | hypothalamic GHRH | ghrelin |
How Does Ipamorelin Compare With Tesamorelin?
Ipamorelin and tesamorelin are complementary research tools: Ipamorelin is a ghrelin receptor agonist and tesamorelin is a GHRH receptor agonist, both supplied as lyophilised peptides. Within our range this is the more useful peptide comparison, since both can be tested under identical handling and certification. The tesamorelin and Ipamorelin 13 plus 3 mg vial serves studies that require both inputs in one preparation. Tesamorelin is stocked in 2mg, 5mg, 10mg and 20mg vials, and Ipamorelin in 10mg vials.
Why Do We Not Sell MK-677?
We do not sell MK-677 because it is a synthetic small molecule, not a peptide, and our range is limited to peptides we can test and certify ourselves. MK-677 is made and characterised by methods different from the solid-phase peptide synthesis, HPLC purity testing and mass spectrometry identity checks we apply to every lot. No peptide lot is released until HPLC shows 98% or higher, and a certificate of analysis is written for that lot alone.
Which Ghrelin or GHRH Receptor Tool Fits the Study?
The right tool depends on which receptor the hypothesis addresses and whether the study needs a pulse or sustained activation. The main options map as follows.
- Acute, selective ghrelin receptor activation: Ipamorelin.
- Dual receptor input on the pituitary: the CJC-1295 and Ipamorelin blend.
- GHRH receptor activation with enzyme resistance: tesamorelin.
- Sustained, orally delivered ghrelin receptor activation in animal models: a small molecule such as MK-677, sourced from a chemical supplier.
Our recommendation: where the question concerns the ghrelin receptor itself, begin with Ipamorelin, because its short action and selectivity make results easier to interpret than the Ipamorelin vs MK-677 alternative of sustained exposure. The full set of secretagogues and GHRH analogues is in our growth hormone research range.
Questions about Ipamorelin vs MK-677
Sources
- Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998.
Written by the Macropus Peptides technical team for in-vitro laboratory research reference. Not medical advice; products are not for human or veterinary use and are sold to buyers aged 18 and over.